ALX Oncology Holdings Inc. (ALXO) Social Stream
ALX ONCOLOGY HOLDINGS INC (ALXO) Price Targets From Analysts
Use the tables below to see what analysts covering ALX ONCOLOGY HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 7 | $106 | $85 | $98.5 | $14.05 | 601.07% |
| 2021-11-11 | 7 | $103 | $60 | $86.666 | $14.05 | 516.84% |
| 2021-11-17 | 7 | $103 | $60 | $83.333 | $14.05 | 493.12% |
| 2021-12-14 | 7 | $103 | $60 | $82 | $14.05 | 483.63% |
| 2021-12-22 | 7 | $103 | $25 | $75.333 | $14.05 | 436.18% |
| 2022-03-01 | 7 | $103 | $19 | $59.666 | $14.05 | 324.67% |
| 2022-04-01 | 7 | $80 | $19 | $52.5 | $14.05 | 273.67% |
| 2022-05-09 | 6 | $80 | $19 | $52.5 | $14.05 | 273.67% |
| 2022-05-16 | 6 | $80 | $12 | $51.166 | $14.05 | 264.17% |
| 2022-06-03 | 6 | $80 | $12 | $47.5 | $14.05 | 238.08% |
| 2022-08-08 | 5 | $80 | $12 | $40.8 | $14.05 | 190.39% |
| 2022-08-09 | 6 | $80 | $12 | $39.333 | $14.05 | 179.95% |
| 2022-11-08 | 6 | $80 | $12 | $40.8 | $14.05 | 190.39% |
| 2022-12-13 | 6 | $65 | $12 | $35.166 | $14.05 | 150.29% |
| 2023-03-09 | 6 | $65 | $12 | $35.5 | $14.05 | 152.67% |
| 2023-03-10 | 6 | $48 | $6 | $28.666 | $14.05 | 104.03% |
| 2023-05-12 | 7 | $48 | $6 | $28 | $14.05 | 99.29% |
| 2023-07-23 | 7 | $48 | $6 | $27.571 | $14.05 | 96.23% |
| 2023-07-24 | 7 | $48 | $6 | $23.857 | $14.05 | 69.8% |
| 2023-08-11 | 7 | $29 | $5 | $15.285 | $14.05 | 8.79% |
| 2023-08-14 | 7 | $29 | $5 | $14.714 | $14.05 | 4.73% |
| 2023-10-04 | 7 | $27 | $8 | $16.785 | $14.05 | 19.47% |
| 2023-11-14 | 7 | $27 | $8 | $15.25 | $14.05 | 8.54% |
| 2023-12-08 | 7 | $27 | $10 | $16.916 | $14.05 | 20.4% |
The Trend in the Analyst Price Target
Over the past 37 months, ALXO's average price target has gone down $44.28.
Over the past 39 weeks, ALXO's average upside potential has been 247.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 6 | 48 | 6 | 27.833 | 5.39 | 416.38% |
| 2023-04-26 | 6 | 48 | 6 | 27.833 | 5.66 | 391.75% |
| 2023-05-12 | 6 | 48 | 6 | 28.000 | 6.53 | 328.79% |
| 2023-08-14 | 7 | 29 | 5 | 14.714 | 4.90 | 200.29% |
| 2023-11-14 | 7 | 27 | 8 | 17.214 | 8.83 | 94.95% |
ALXO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
ALXO's average broker recommendation rating improved by 0.29 over the prior 31 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALXO as an investment opportunity.
- In terms of how ALX ONCOLOGY HOLDINGS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2558.8% of that group.
- ALX ONCOLOGY HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 2239.62% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ALX ONCOLOGY HOLDINGS INC's average analyst price target is greater than 1493.26% of them.
- ALX ONCOLOGY HOLDINGS INC's number of analysts covering the stock is higher than 1141.96% of stocks in the mid market cap category.
Stocks similar to ALX ONCOLOGY HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HRMY, PRLD, and PMVP.
View All Top Stocks by Price Target
Is ALXO a Buy, Hold or Sell? See the POWR Ratings now!